Cargando…
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling
Background: Bone is a frequent site of metastases from breast cancer, but existing therapeutic options are not satisfactory. Although osteoblasts have active roles in cancer progression by assisting the vicious bone-destructive cycle, we employed a counterintuitive approach of activating pro-tumorig...
Autores principales: | Sun, Xun, Li, Kexin, Hase, Misato, Zha, Rongrong, Feng, Yan, Li, Bai-Yan, Yokota, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692912/ https://www.ncbi.nlm.nih.gov/pubmed/34976221 http://dx.doi.org/10.7150/thno.66148 |
Ejemplares similares
-
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum
por: Sun, Xun, et al.
Publicado: (2023) -
Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2022) -
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
por: Sun, Xun, et al.
Publicado: (2022) -
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019) -
HSP90AB1 Is a Host Factor Required for Transmissible Gastroenteritis Virus Infection
por: Song, Daili, et al.
Publicado: (2023)